Variant report
Variant | nsv1033762 |
---|---|
Chromosome Location | chr5:101060073-101096015 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:101078843..101080982-chr5:101098462..101100344,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560843891 | chr5:101064639-101064640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564281905 | chr5:101064668-101064669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145631074 | chr5:101064687-101064688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370510879 | chr5:101064846-101064847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76050555 | chr5:101064860-101064861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190501714 | chr5:101064861-101064862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183112366 | chr5:101064874-101064875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551695887 | chr5:101064926-101064927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569970626 | chr5:101064932-101064933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377474123 | chr5:101064948-101064949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148706415 | chr5:101064990-101064991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142271546 | chr5:101065008-101065009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs80022509 | chr5:101065048-101065049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558654775 | chr5:101065095-101065096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs151285002 | chr5:101065119-101065120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553189354 | chr5:101065135-101065136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577810125 | chr5:101065146-101065147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545183904 | chr5:101065156-101065157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370272984 | chr5:101065157-101065158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575585542 | chr5:101065189-101065190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542663469 | chr5:101065194-101065195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187000580 | chr5:101065270-101065271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116045214 | chr5:101065282-101065283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528055632 | chr5:101065286-101065287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554796839 | chr5:101065316-101065317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11959481 | chr5:101065334-101065335 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs564818107 | chr5:101065413-101065414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533355268 | chr5:101065418-101065419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529497633 | chr5:101065445-101065446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117608600 | chr5:101065503-101065504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373730004 | chr5:101065528-101065529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531075952 | chr5:101065531-101065532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192731988 | chr5:101065532-101065533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75531046 | chr5:101065577-101065578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532504191 | chr5:101065599-101065600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182817722 | chr5:101065603-101065604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140599412 | chr5:101065665-101065666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187780428 | chr5:101065707-101065708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73781039 | chr5:101065708-101065709 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs557161319 | chr5:101065711-101065712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76328670 | chr5:101065776-101065777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533414013 | chr5:101065789-101065790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190341353 | chr5:101081429-101081430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573263487 | chr5:101081454-101081455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138689541 | chr5:101081490-101081491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559314192 | chr5:101081495-101081496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565331999 | chr5:101081502-101081503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532226326 | chr5:101081504-101081505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550714727 | chr5:101081505-101081506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562530210 | chr5:101081593-101081594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:101064600-101064800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr5:101064800-101065400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:101064800-101065600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr5:101064800-101065800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr5:101081400-101082000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr5:101090800-101092200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr5:101093800-101094000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr5:101093800-101094200 | Enhancers | Pancreas | Pancrea |
9 | chr5:101094200-101095200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr5:101095200-101096200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr5:101095200-101096200 | Enhancers | Adipose Nuclei | Adipose |